SYLVESTER, Richard

Email Alert RSS Feed

Profile

Full Name

SYLVESTER, Richard

Loading... 5 0 5 0 false

Loading... 6 0 5 0 false

Publications

@UHasselt

All

Author

Category

1 Journal Contribution - Article

Date issued

Type

36 Journal Contribution

Fulltext

1 No Fulltext

Internal UHasselt

Results 21-36 of 36 (Search time: 0.019 seconds).

1
2

Bibtex Excel CSV FWO

		Issue Date	Title	Contributor(s)	Type	Cat.
	21	1997	Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European organization for research and treatment of cancer randomized phase III trial	Bartelink, H.; Rubens, R.D.; van der Schueren, E.; SYLVESTER, Richard	Journal Contribution
	22	1997	Analysis and presentation	Friberg, S.; Taube, A.; SYLVESTER, Richard; Oesterling, J.E.	Journal Contribution
	23	1997	Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a multi-institutional Medical Research Council/ European Organization for Research and Treatment of Cancer Trial	Horwich, A.; Sleijfer, D.T.; Fossa, S.D.; Kaye, S.B.; Oliver, R.T.D.; Cullen, M.H.; Mead, G.M.; de Wit, R.; de Mulder, P.H.M.; Dearnaley, D.P.; Cook, P.A.; Stenning, S.P.; SYLVESTER, Richard	Journal Contribution
	24	1997	Does isoniazed reduce side effects of intravesical Bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of EORTC protocol 30911	Vegt, P.; van der Meijden, A.; SYLVESTER, Richard; Brausi, M.; Holtl, W.; de Balincourt, C.	Journal Contribution
	25	1997	Importance of bleomycin in combination chemotherapy for good prognosis testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group	de Wit, R.; Stoter, G.; Kaye, S.B.; Steijffer, D.Th.; Jones, W.G.; ten Bokkel Huinink, W.W.; Rea, L.A.; Collette, L.; SYLVESTER, Richard	Journal Contribution
	26	1997	Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminatomous testicular cancer	de Wit, R.; SYLVESTER, Richard; Tsitsa, C.; de Mulder, P.H.M.; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G.	Journal Contribution
	27	1996	Marker tumour response to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours	van der Meijden, A.P.M.; Hall, R.R.; Pavone Macaluso, M.; Pawinski, R.; SYLVESTER, Richard; van Glabbeke, M.	Journal Contribution
	28	1996	Phase II trails in Ta, T1 bladder cancer: the marker tumour concept	van der Meijden, A.P.M.; Hall, R.R.; Kurth, K.H.; Bouffioux, Ch.; SYLVESTER, Richard	Journal Contribution
	29	1996	Prognostic factors in metastatic prostate cancer	SYLVESTER, Richard	Journal Contribution
	30	1996	A combined analysis of European Organization for Research and Treatment of Cancer and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer	Pawinski, R.; SYLVESTER, Richard; Kurth, K.; Bouffioux, Christophe; van der Meijden, A.; Parmar, M.; BIJNENS, Luc	Journal Contribution
	31	1996	The role of biostatistics in cancer research	SYLVESTER, Richard	Journal Contribution
	32	1996	Can the forest plot be simplified without loosing relevant information in meta-analyses?	BIJNENS, Luc; SYLVESTER, Richard; Collette, L.; Ivanov, A.; Hoctin, Boes G.	Journal Contribution
	33	1995	EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma	de Mulder, P.H.M.; Oosterhof, G.O.N.; Bouffioux, Christophe; van Oosterom, A.T.; Vermeylen, K.; SYLVESTER, Richard	Journal Contribution
	34	1994	Surveillance of stage 1 non-seminomatous testicular cancer: a preliminary report of the EORTC GU-Cooperative Group Surveillance Study	van Oosterom, A.T.; Vendrik, G.; Keizer, J.; Droz, J.P.; Schornagel, J.; Croles, J.; Splinter, T.; ten Kate, F.; Vermeylen, K.; SYLVESTER, Richard	Journal Contribution
	35	1991	High-dose DTIC in advanced soft-tissue sarcomas in the adult	Buesa, J.M.; Mouridsen, H.T.; van Oosterom, A.T.; Verweij, J.; Wagener, T.; Steward, W.; Poveda, A.; Vestlev, P.M.; Thomas, D.; SYLVESTER, Richard	Journal Contribution
	36	1991	Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery	Jansen, R.L.H.; SYLVESTER, Richard; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; Jones, W.G.; Keizer, J.; van Oosterom, A.T.; Meyer, S.; Vendrik, C.P.J.; de Pauw, M.; Stoter, G.	Journal Contribution

1
2